How A Healthcare Expert Network Is Powering Startup Growth

A meeting of medical and business experts collaborating at a healthcare startup—illustrating the kind of cross-functional teamwork that MDisrupt’s healthcare expert marketplace make possible.

getty

As venture capital flows back into healthcare, startups need more than funding: They need expertise. MDisrupt’s AI-powered healthcare expert network connects them with the talent that drives innovation.

Healthcare’s Resilient Investment Boom

After two volatile years, venture capital is finding its footing in healthcare again. U.S. healthcare startups raised about $23 billion in 2024, up from roughly $20 billion in 2023, as investors regained confidence in digital health, biotech, and AI-driven innovation. The global healthcare market, valued at about $11 trillion in 2024, is projected to reach nearly $17.5 trillion by 2032.

This rebound marks a comeback from the pandemic highs and subsequent correction of 2022. Venture capitalists who once chased consumer tech are turning back to healthcare, where demographic demand and digital transformation are rewriting the playbook. Aging populations, chronic disease management, and AI-driven care models are fueling massive opportunities for startups that can pair science with scalability.

Momentum is also being reignited by a new wave of drivers: AI and predictive healthcare are capturing the lion’s share of new funding; infrastructure and enablement plays—such as data interoperability, regulatory tools, and healthcare expert marketplaces—are gaining traction; M&A and strategic exits are expected to rise; and hybrid private equity–VC models are injecting longer-term capital into healthcare innovation.

Healthcare Expertise: Why Startups Need More Than Capital

Even as VC investments return to the sector, founders face a persistent problem: expertise. Unlike traditional tech, where a small engineering team can build a minimum viable product, healthcare innovation demands specialized knowledge across multiple disciplines—clinical validation, medical expertise, scientists, regulatory strategy, reimbursement, data science, and payer relationships, to name a few. Each one is critical to proving a product’s safety, efficacy, and path to market.

Hiring full-time leaders in all these areas is out of reach for most early-stage companies. That’s the gap MDisrupt aims to fill.

“Healthcare innovation is built on evidence and trust, but those take time and expertise to get right,” shared Ruby Gadelrab, founder and CEO of MDisrupt. “We’re helping startups move faster without cutting corners by connecting them to experts who’ve done it before—people who understand the science, regulation, and commercial realities of healthcare.”

MDisrupt, based in Austin, operates a healthcare expert marketplace that connects startups and others with vetted professionals—clinicians, regulatory strategists, payers, scientists, and commercial leaders—on a fractional or project basis. The idea is to make expertise as accessible as technology, giving young companies the same depth of knowledge that large organizations rely on, but without the cost or overhead of traditional hiring.

For early-stage founders, that access can mean the difference between staying afloat and scaling successfully.

“MDisrupt’s model has unlocked the talent and agility we need to scale innovative projects in a capital-efficient way,” noted Leslie Wilberforce, CEO of Evidat. “They are enabling a new model for companies like ours to grow and access diverse expertise for innovation.”

Healthcare innovation often requires navigating a complex maze of compliance, clinical trials, and payer relationships. That’s why founders like Kelly Lacob, CEO and co-founder of Xella, turn to MDisrupt’s healthcare expert network to close execution gaps fast.

“What has impressed me most about MDisrupt is how well they understand the realities of building in healthtech,” Lacob said. “We brought on fractional talent in computational biology, bioinformatics, and clinical operations who helped us hit critical milestones faster than we could have imagined—and we ended up hiring one of them full-time as our VP of Computational Biology.

Building Infrastructure With A Healthcare Expert Network

MDisrupt’s healthcare expert network now includes thousands of specialists across the healthcare value chain. Startups can book fractional engagements in areas ranging from clinical operations to regulatory submissions and commercial strategy, shortening development timelines that once stretched months or years. The platform handles vetting, contracts, and compliance—eliminating much of the administrative friction that slows innovation.

“Healthcare moves at the speed of trust,” Gadelrab said. “Our mission is to make trusted expertise as accessible as technology”.

That mission recently gained a powerful endorsement. The American Heart Association Ventures invested $1 million in MDisrupt to co-develop a platform connecting innovators and clinicians, marking a rare institutional partnership between a century-old health organization and a startup. The investment signaled not only validation for MDisrupt’s model but also a broader recognition that scaling healthcare innovation now requires new kinds of infrastructure.

The AHA’s interest highlights a shift in how traditional institutions engage with emerging companies. Instead of acting as gatekeepers, organizations like the AHA are becoming catalysts—investing in platforms that help translate scientific advances into scalable products. MDisrupt’s healthcare expert marketplace offers a model for that bridge-building: It gives early-stage startups access to institutional-grade knowledge while helping established organizations identify promising innovations faster.

Overcoming Challenges To Build A Healthcare Expert Network

MDisrupt’s rise wasn’t without obstacles. When Gadelrab launched the company in 2019, the term “healthcare expert marketplace” didn’t exist. Investors were cautious, struggling to grasp how a service model could scale in an industry known for regulation and slow adoption.

“It wasn’t easy explaining to investors that healthcare needed a marketplace model,” Gadelrab said. “People understood the gig economy, but not how it could apply to medicine or science. We had to prove that a vetted network of experts could improve outcomes—not dilute standards.”

The fundraising process was complicated. Gadelrab was building a company at the intersection of two male-dominated industries—venture capital and healthcare technology. Convincing investors to back a woman of color with an unconventional business model took persistence and data.

“Raising money was the hardest part,” Gadelrab sighed. “I was told the idea was too early, too risky, or too niche. So I stopped pitching vision and started showing traction—revenue growth, repeat clients, and the caliber of experts joining the network. Once people saw results, the conversations changed.” Metrics, not the challenges women or people of color face in raising capital, are what excite most investors, especially men, who write bigger checks than women.

Gadelrab’s early struggles shaped MDisrupt’s ethos. Every process, from expert onboarding to client matching, was built to withstand scrutiny. “Being underestimated taught me to build a business that couldn’t be ignored,” she explained. “Our results had to speak louder than our story.”

By 2024, MDisrupt’s healthcare expert network had grown exponentially, and the company was profitable. Today, its experts span every central functional area—from clinical operations and regulatory affairs to go-to-market strategy—and serve startups across diagnostics, digital health, and therapeutics.

Healthcare Expertise As The Next Catalyst

If capital fueled healthcare’s last decade of growth, expertise will drive the next. As the industry grows more complex, founders must master science, regulation, and patient trust all at once. The healthcare expert marketplace offers a scalable way to do that—aligning innovation with both investor expectations and accountability.

In such a complex field, connecting innovators with trusted healthcare experts isn’t optional; it’s essential. By matching startups with proven leaders in real time, MDisrupt is building the infrastructure that turns innovation into impact.

For investors betting on the next wave of breakthroughs, access to a network of vetted healthcare experts may be the most valuable asset of all. “We’re not just matching experts with startups,” Gadelrab noted. “We’re building the systems that make innovation in healthcare more reliable, more inclusive and, ultimately, more human.”